Immune Diseases - IMHA Flashcards

Everything about Immune Mediated Hemolytic Anemia in small animals (39 cards)

1
Q

Age predisposition of IMHA of both dogs and cats

A

Dogs - Middle aged; 6.5yrs avg (13wks-13yrs)
Cats - Young/middle aged; 3yrs (6mths-9yrs)
Any age can be affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Breed disposition of IMHA

A

Dogs - 1/3 of all cases are Cocker Spaniels (also Springer, Poodles, OESDs etc.)
Cats - no predispositions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gender predisposition of IMHA

A

Dogs - Female

Cats - Male

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does vaccination influence IMHA

A

25% of dogs had been vaccinated within days of diagnosis in one study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IMHA seasonal incidence?

A

Spring and summer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Infectious (secondary) causes of RBC destruction in IMHA include

A

1) Tick-bourne diseases
2) Babesia spp.
3) Dirofilaria immitis
4) Microfilaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Toxic (secondary) causes of RBC destruction in IMHA include

A

1) Zinc
2) Acetaminophen
3) Onions/garlic
4) Copper
5) Castor beans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drug related (secondary) causes of RBC destruction in IMHA include

A

Penicillin, Cephalosporins, Sulfonamides, Quinidine, Procainamide, Phenothiazines, Methylene blue, Methimazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Neoplastic (secondary) causes of RBC destruction in IMHA include

A

Hemolymphatic tumors and Solid tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Immune (secondary) causes of RBC destruction in IMHA include

A

SLE and hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metabolic (secondary) causes of RBC destruction in IMHA include

A

Hypophophataemia (severe)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inherited / intrinsic RBC defects in IMHA include

A

PFK deficiency and PK deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain the pathophysiology of IMHA

A

Increase in procoagulant activity, decrease in anticoagulant activity, decreased fibrinolysis = Thromboembolism, DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mucous membranes physical exam findings in IMHA

A

Pale
+/- icteric
+/- petechia/ecchymoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Temperature physical exam findings in IMHA

A

Dogs - Pyrexia

Cats - Hypothermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pulse physical exam findings in IMHA

A

Tachycardia
+/- prominent pulses
+/- anemic murmur

17
Q

Respiratory physical exam findings in IMHA

A

Tachypnea

+/- respiratory distress

18
Q

Abdominal palpation physical exam findings in IMHA

A

Hepatosplenomegly and Abdominal pain

19
Q

IMHA most common clinical signs

A

Lethargy, depression, anorexia

20
Q

IMHA less common clinical signs

A
Vomiting & Diarrhea
PU/PD
Weakness
Exercise Intolerence
Collapse/ syncope
Pigmenturia
Respiratory distress
Pica
21
Q

CBC results for IMHA

A
Moderate to severe regenerative anemia
Neutrophilic leukocytosis
Thrombocytopenia
Normal TP (rules out blood loss)
Evidence of RBC destruction (spherocytosis, autoagglutionation, +ve Coomb's test)
22
Q

Describe Saline/ slide agglutination test

A

1 drop blood + 1-2 drops saline
Agitate gently (rock back & forth)
Check for both micro and macroscopic agglutination
+ve in 40-89% IMHA dogs

23
Q

Biochemistry results for IMHA

A

Increase Tbilirubin, ALT

+/- azotemia

24
Q

Urinanalysis results for IMHA

A

Bilirubinuria

+/- hemoglobinuria

25
Imaging results for IMHA
To rule out secondary causes Thoracic Radio: patchy alveolar opacities, pronounced interstitial pattern, mid pleural effusion (PTE) Abdominal Ultra: Hepatosplenomegaly, extramedullary hematopoiesis
26
Bone marrow aspirate / biopsy for IMHA
Non regenerative anemia
27
Coagulation parameters for IMHA
If DIC present; Increase ACT, PT/PTT etc. | Other test Thromboelastography
28
Treatment for IMHA
Immunosuppression, reduce risk of thrombosis with anticoagulants and antiplatelet drugs, doxycyline and supportive care
29
1st line steroids (immunosuppression) for treatment of IMHA
Prednisone (2-4mg/kg/day) PO | Dexamethasone SQ or IV if can't tolerate PO medications
30
2nd line steroids (immunosuppression) for treatment of IMHA
Azathioprine, Cyclosporine, Mycophenolate mofetil
31
Anticoagulants (antithrombotics) used for the treatment of IMHA
Unfractured heparin (UFH) IV or SQ Low molecular weight heparin (LMWH) SQ Coumadin/warfarin PO Require monitoring
32
Antiplatelet drugs (antithrombotics) used for the treatment of IMHA
Aspirin Clopidogrel Doesn't require monitoring
33
Supportive treatment for IMHA
Blood transfusion (in severely anemic patients if hemodynamically unstable, required in 70-90% of dogs, PRBCs preferred) Oxygen therapy IVF therapy GI protectants (Antacids - H2 blocker/ proton pump inhibitor/ PG analogue; Sucralfate)
34
Long term management of IMHA
History, PE, and CBC once to twice until resolution of anemia Biweekly until tappering of immunosuppressive medications is initiated Maintenance of immunosuppressive glucocorticoid dose until Hct is stable or rising followed by 25-50% dosage reduction every 2-4wks (withdrawal 3-6mths) CBC prior to each dosage reduction
35
Complications in IMHA
``` Pulmonary thromboembolism (PTE) - most common cause of death in IMHA dogs ```
36
IMHA prognosis
Guarded Dogs - 26-70% mortality; highest in first two weeks after diagnosis. May die suddenly even if anemia has resolved or relapse during treatment. Cats - 24% mortality
37
Favorable criteria for IMHA
Response to treatment (rise in Hct within 3-7days) | Response to transfusion
38
Unfavorable criteria for IMHA
Persistent agglutination despite immunosuppression drug Thrombocytopenia Leukocytosis +/- left shift Use of cyclophosphamide
39
IMHA vaccine
None